291 related articles for article (PubMed ID: 26840056)
1. Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome.
Bassan F; Bassan R; Esporcatte R; Santos B; Tura B
Arq Bras Cardiol; 2016 Mar; 106(3):218-25. PubMed ID: 26840056
[TBL] [Abstract][Full Text] [Related]
2. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
Bassan R; Tura BR; Maisel AS
Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
[TBL] [Abstract][Full Text] [Related]
3. Additional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndrome.
García-Alvarez A; Regueiro A; Hernández J; Kasa G; Sitges M; Bosch X; Heras M
Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):132-40. PubMed ID: 24448752
[TBL] [Abstract][Full Text] [Related]
4. A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.
Ndrepepa G; Braun S; Mehilli J; Niemöller K; Schömig A; Kastrati A
Clin Res Cardiol; 2007 Jan; 96(1):30-7. PubMed ID: 17066344
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of B-type natriuretic peptide in the mortality of patients with acute coronary syndrome.
Scotti AV; Tura BR; Rocha RG; Albuquerque DC
Arq Bras Cardiol; 2012 Jul; 99(1):605-12. PubMed ID: 22641392
[TBL] [Abstract][Full Text] [Related]
6. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
[TBL] [Abstract][Full Text] [Related]
8. Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study.
Glaser R; Peacock WF; Wu AH; Muller R; Möckel M; Apple FS
Am J Cardiol; 2011 Mar; 107(6):821-6. PubMed ID: 21247525
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.
Helanova K; Littnerova S; Kubena P; Ganovska E; Pavlusova M; Kubkova L; Jarkovsky J; Pavkova Goldbergova M; Lipkova J; Gottwaldova J; Kala P; Toman O; Dastych M; Spinar J; Parenica J
BMJ Open; 2015 Oct; 5(10):e006872. PubMed ID: 26438132
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of B-type natriuretic peptide levels on admission in patients with acute ST elevation myocardial infarction.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Rudzki D; Główczyńska R; Rudowski R; Opolski G
Acta Cardiol; 2005 Oct; 60(5):537-42. PubMed ID: 16261786
[TBL] [Abstract][Full Text] [Related]
11. Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction.
Hashimoto T; Ishii J; Kitagawa F; Yamada S; Hattori K; Okumura M; Naruse H; Motoyama S; Matsui S; Tanaka I; Izawa H; Maruyama I; Nomura M; Ozaki Y
Atherosclerosis; 2012 Apr; 221(2):490-5. PubMed ID: 22369934
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.
He PC; Duan CY; Liu YH; Wei XB; Lin SG
BMC Cardiovasc Disord; 2016 Dec; 16(1):255. PubMed ID: 27955618
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.
Brügger-Andersen T; Pönitz V; Staines H; Pritchard D; Grundt H; Nilsen DW
BMC Cardiovasc Disord; 2008 Nov; 8():34. PubMed ID: 19032759
[TBL] [Abstract][Full Text] [Related]
14. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
[TBL] [Abstract][Full Text] [Related]
16. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation.
Bassan R; Potsch A; Maisel A; Tura B; Villacorta H; Nogueira MV; Campos A; Gamarski R; Masetto AC; Moutinho MA
Eur Heart J; 2005 Feb; 26(3):234-40. PubMed ID: 15618053
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes.
Omland T; Persson A; Ng L; O'Brien R; Karlsson T; Herlitz J; Hartford M; Caidahl K
Circulation; 2002 Dec; 106(23):2913-8. PubMed ID: 12460871
[TBL] [Abstract][Full Text] [Related]
19. Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome.
Lillpopp L; Tzikas S; Ojeda F; Zeller T; Baldus S; Bickel C; Sinning CR; Wild PS; Genth-Zotz S; Warnholtz A; Lackner KJ; Münzel T; Blankenberg S; Keller T
Am J Cardiol; 2012 Nov; 110(9):1225-30. PubMed ID: 22818785
[TBL] [Abstract][Full Text] [Related]
20. In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.
Oduncu V; Erkol A; Tanalp AC; Dündar C; Tanboğa IH; Sırma D; Karagöz A; Karabay CY; Izgi A; Pala S; Tigen K; Kırma C
Turk Kardiyol Dern Ars; 2011 Oct; 39(7):540-8. PubMed ID: 21983763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
